EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of unbiased metagenomic next generation sequencing to targeted multiplex diagnostic assays for the detection of respiratory viruses

Justin Hardick, Raghavendran Anantharam iD, Jennifer Lu, Steven L Salzberg iD, Richard E Rothman, Katherine Z J Fenstermacher, Andrew Pekosz iD, Annet Onzia, Lydia Nakiyingi, Yukari C Manabe, Abraham J Kandathil iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0347750 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS One, 2026. Verfasst von Justin Hardick und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Metagenomics, Respiratory Tract Infections, RNA Viruses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, NIGMS NIH HHS, Johns Hopkins Center of Excellence for Influenza Research and Response.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Accurate diagnosis of existing and emerging respiratory pathogens is important. We evaluated the capability of unbiased metagenomic next generation sequencing (mNGS) to identify pathogenic RNA viruses from two cohorts of nasopharyngeal (NP) swabs previously tested by commercial multiplex respiratory diagnostics.

Methods

NP swabs (N = 100) in viral transport media (VTM) were assessed using mNGS for this study. Cohort 1 (N = 52) consisted of symptomatic individuals who tested negative for SARS-CoV-2, influenza A/B, and RSV by the Xpert Xpress CoV-2/Flu/RSV Plus multiplex respiratory virus panel and were tested by mNGS for undetected pathogens. Cohort 2 (N = 48) included symptomatic individuals who were positive (N = 26) or negative (N = 22) by the ePlex RP2 multiplex respiratory pathogen panel. Samples were positive for influenza A (N = 8), rhinovirus/enterovirus (N = 5), RSV (N = 4), adenovirus (N = 3), parainfluenza (N = 2), seasonal coronaviruses (N = 2), and human metapneumovirus (N = 1), as well as a rhinovirus/enterovirus/human metapneumovirus co-infected sample (N = 1). mNGS results were compared with ePlex RP2 findings, and symptomatic negative samples were evaluated for additional pathogen detection.

Results

Cohort 1 contained 8% (4/52) viral and 19% (10/52) bacterial reads. In cohort 2, positive concordance between ePlex RP2 and mNGS was 31% (8/26). mNGS did not identify any viral reads in ePlex RP2-negative samples. However, it detected other microbial reads, such as Acanthamoeba castellanii, in 21% (10/48) of samples.

Conclusion

In this study, targeted multiplex amplification methods demonstrated better overall sensitivity in NPs of symptomatic respiratory individuals than mNGS. Other mNGS approaches may produce different results. This study suggests that mNGS may offer adjunctive information, including the detection of rare pathogens, which may be helpful in some clinical contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingMetagenomicsRespiratory Tract InfectionsRNA VirusesHumansNasopharynxMultiplex Polymerase Chain Reaction

Autor:innen und Institutionen

  • Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Departments of Computer Science and Biostatistics, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Division of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.

ORCID-Profile: Raghavendran Anantharam, Steven L Salzberg, Andrew Pekosz, Abraham J Kandathil

Förderung

  • NHGRI NIH HHS
  • NIGMS NIH HHS
  • Johns Hopkins Center of Excellence for Influenza Research and Response
  • National Institutes of Health

Zitieren

APA

Hardick, J., Anantharam, R., Lu, J., Salzberg, S. L., Rothman, R. E., Fenstermacher, K. Z. J., Pekosz, A., Onzia, A., Nakiyingi, L., Manabe, Y. C., & Kandathil, A. J. (2026). Comparison of unbiased metagenomic next generation sequencing to targeted multiplex diagnostic assays for the detection of respiratory viruses. PLOS One. https://doi.org/10.1371/journal.pone.0347750

Vancouver

Hardick J, Anantharam R, Lu J, Salzberg SL, Rothman RE, Fenstermacher KZJ, et al. Comparison of unbiased metagenomic next generation sequencing to targeted multiplex diagnostic assays for the detection of respiratory viruses. PLOS One. 2026. doi:10.1371/journal.pone.0347750

BibTeX
@article{Hardick2026,
  author = {Hardick, Justin and Anantharam, Raghavendran and Lu, Jennifer and Salzberg, Steven L and Rothman, Richard E and Fenstermacher, Katherine Z J and Pekosz, Andrew and Onzia, Annet and Nakiyingi, Lydia and Manabe, Yukari C and Kandathil, Abraham J},
  title = {Comparison of unbiased metagenomic next generation sequencing to targeted multiplex diagnostic assays for the detection of respiratory viruses},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0347750}
}
Kostenlos starten →